-
Posted by
Two Blokes May 20, 2025 -
Filed in
Stock
-
5 views
UnitedHealth Group Incorporated has faced negative catalysts—guidance withdrawal, CEO change, DOJ probe rumors, and PBM threats—driving the stock down sharply. Insiders, including the CEO and CFO, have aggressively bought shares, signaling confidence and helping stabilize the stock after a steep drop. Despite short-term uncertainty, I believe fears are overblown and UNH remains a solid, defensive long-term investment at a compelling valuation.
